- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06086028
LA-CEAL 4.0: Wearable Sensor Project
September 30, 2025 updated by: Tulane University
LA-CEAL 4.0: Louisiana (LA) Community-Engagement Research Alliance (CEAL): Wearable Sensor Project
The study seeks to explore the efficacy of biofeedback collected via a wrist worn sensor in helping healthcare workers self-manage symptoms of stress and burnout.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A randomized two-group cross over design will be used to test the hypothesis that using real-time biofeedback to present, interpret, and bring attention to information regarding stress levels will increase participants readiness to change in regard to addressing burnout.
To test this hypothesis, the investigators will recruit 80 providers from Federally Qualified Health Centers (FQHC) partner sites to participate in a 6-week cross over design.
The study includes two feedback periods: (1) 21 days of immediate information: (2) 21 days delayed information period.
Participant conditions will be switched on day 22.
All participants will be given a wrist worn sensor developed by Biostrap.
Biostrap collects biometrics such as the following: (1) sleep pattern/ quality; (2) steps, activity, calories; (3) heart rate/ Heart Rate Variability (HRV); (4) respiratory rate.
Participants will be randomly assigned to one of two groups, and either receive immediate or delayed feedback from the sensor first and will then be crossed-over to receive the opposite type of feedback.
While wearing the Biostrap wrist-worn sensor, participants will be asked to complete two daily questions sent via the API.
The first question seeks to determine if participants accurately understand their biometric data and will ask "how stressed are you today?" (Scale 1-10).
The second question seeks to determine if participants attended to the information regarding their stress level and will ask "did you complete a self-care activity today?" (yes/no).
A pre and post assessment will be given before and after completing the six-week wearable protocol.
Items will include: (1) 2-item depression screener (Patient Health Questionnaire-revised) (2) 2-item anxiety screener (Generalized Anxiety Disorder Scale- revised) (3) 4-item brief resilient coping scale (4) 22-item burnout assessment (Maslach Burnout Inventory) (5) Self-care/supportive psychosocial programs utilization(e.g., I participate in an employee wellness program through my employer) (yes/no) (6) Basic demographics (e.g., age, sex, race, ethnicity, job category, years in field) (7) Familiarity and self-efficacy using wearable sensors (8) Self- report medication list (pretest only).
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70112
- Tulane School of Public Health and Tropical Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age >=18 years.
- Ability to understand and speak English.
- Staff at FQHC.
- Smartphone compatible with the Biostrap sensor and phone application.
- Attending work during the six week study period.
Exclusion Criteria:
- Unable or unwilling to give informed consent.
- Disclosed pregnancy at the start of the study.
- Pace maker or other device regulation heart rate/rhythm.
- Previous diagnosis of atrial fibrillation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Immediate then Delayed Arm
The participants will receive immediate access to the data from the wearable sensor for 21 days.
On day 22, all of the data from the wearable sensor will be hidden from the participant (delayed) until after the second 21-day feedback period.
Wrist worn sensor: Biostrap collects biometrics such as the following: (1) sleep pattern/ quality; (2) steps, activity, calories; (3) heart rate/ HRV; (4) respiratory rate.
|
Biostrap collects biometrics such as the following: (1) sleep pattern/ quality; (2) steps, activity, calories; (3) heart rate/ HRV; (4) respiratory rate.
Participants will be randomly assigned to one of two groups.
|
|
Experimental: Delayed then Immediate Arm
The participants begin the first 21-day feedback period with their data from the wearable sensor hidden (delayed feedback).
On day 22, the wearable sensor changes to become available in real time (immediate feedback) for the second 21-day feedback period.
Wrist worn sensor: Biostrap collects biometrics such as the following: (1) sleep pattern/ quality; (2) steps, activity, calories; (3) heart rate/ HRV; (4) respiratory rate.
|
Biostrap collects biometrics such as the following: (1) sleep pattern/ quality; (2) steps, activity, calories; (3) heart rate/ HRV; (4) respiratory rate.
Participants will be randomly assigned to one of two groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Days in Concordance Comparing Immediate Information Period With Delayed Information Period
Time Frame: 6 weeks
|
The proportion of days in concordance was calculated based on responses to two questions.
The first question seeks to determine if participants accurately understand their biometric data and will ask "how stressed are you today?" (Scale 1-10 a score of 6+ was coded as "high stress").
The second question seeks to determine if participants attended to the information regarding their stress level and will ask "did you complete a self-care activity today?" (yes = 1 /no = 0).
Concordance was coded when participants either a) reported a high level of stress and engaged in self-care or b) when participants reported low levels of stress and did not engage in self-care.
Percentage of days in concordance was calculated for both 21-day feedback periods (immediate versus delayed).
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Burnout Score From Baseline to Follow-up (Pre/Post Sensor Data Collection)
Time Frame: Baseline - 6 weeks
|
The investigators measured the change in the burnout score in all participants between baseline and 6 weeks follow-up.
Maslach Burnout Inventory - Human Services Survey for Medical Personnel (MBI-HSS-MP) is a 22-item survey that covers 3 areas: Emotional Exhaustion (EE), Depersonalization (DP), and low sense of Personal Accomplishment (PA).
Each subscale includes multiple questions with frequency rating choices of Never (0), A few times a year or less, Once a month or less, A few times a month, Once a week, A few times a week, or Every day (6).
The total score is calculated by summing the three sub-scales and ranges from 0-132 with high scores reflecting higher symptoms of burnout and low scores reflecting fewer symptoms of burnout.
|
Baseline - 6 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mean in Total Burnout Score of Immediate Then Delayed Arm to Delayed Then Immediate Arm
Time Frame: Baseline - 6 weeks
|
The investigators measured the mean in the total burnout score of the immediate then delayed arm to the delayed then immediate arm.
Maslach Burnout Inventory - Human Services Survey for Medical Personnel (MBI-HSS-MP) is a 22-item survey that covers 3 areas: Emotional Exhaustion (EE), Depersonalization (DP), and low sense of Personal Accomplishment (PA).
Each subscale includes multiple questions with frequency rating choices of Never (0), A few times a year or less, Once a month or less, A few times a month, Once a week, A few times a week, or Every day (6).
The total score is calculated by summing the three sub-scales and ranges from 0-132 with high scores reflecting higher symptoms of burnout and low scores reflecting fewer symptoms of burnout.
|
Baseline - 6 weeks
|
|
Change in Mean in Total Depression Score of Immediate Then Delayed Arm to Delayed Then Immediate Arm
Time Frame: Baseline - 6 weeks
|
The investigators compared the mean in total depression score of immediate then delayed arm to delayed then immediate arm.
The score is a 2-item depression screener (Patient Health Questionnaire-revised).
The range is from 0 to 6.
The high scores reflect higher symptoms of depression, and low scores reflect fewer symptoms of depression.
|
Baseline - 6 weeks
|
|
Change in Mean in Total Anxiety Score of Immediate Then Delayed Arm to Delayed Then Immediate Arm
Time Frame: Baseline - 6 weeks
|
The investigators compared the mean in total anxiety score of immediate then delayed arm to delayed then immediate arm.
The score is a 2-item anxiety screener (Generalized Anxiety Disorder Scale- revised).
The range is from 0 to 6.
The high scores reflect higher symptoms of anxiety, and low scores reflect fewer symptoms of anxiety.
|
Baseline - 6 weeks
|
|
Change in Mean in Total Resilience Score of Immediate Then Delayed Arm to Delayed Then Immediate Arm
Time Frame: Baseline - 6 weeks
|
The investigators compared the mean in total resilience score of immediate then delayed arm to delayed then immediate arm.
The score is a 4-item brief resilient coping scale.
The range is from 4 to 20.
The high scores reflect higher resilience, and low scores reflect lower resilience.
|
Baseline - 6 weeks
|
|
Change in Mean on Participant Sleep Score Between Immediate Information Period and Delayed Information Period
Time Frame: 6 weeks
|
The investigators measured the change in the participant sleep efficiency score in all participants between the 2 conditions to compare the difference across the conditions.
Sleep efficiency score is measured via the wearable sensor.
It is comprised of the following information: sleep duration (end-start), minutes in light sleep, minutes in deep sleep, stages of sleep (e.g.
REM), arousal count.
The range is from 0 to 100.
Higher sleep efficiency scores reflect better quality sleep.
Low sleep efficiency scores reflect poor quality of sleep
|
6 weeks
|
|
Change in Mean on Participant Activity Level Score Between Immediate Information Period and Delayed Information Period
Time Frame: 6 weeks
|
Activity level was measured by number of steps and distance measured by the wearable sensors.
Higher scores reflect more activity while lower scores reflect less activity.
An average of the daily activity level scores was calculated for each information period.
Biostrap company calculated the activity score using the activity distribution over the course of a 24-hour window, emphasizing consistent physical activity of 500 steps per hour during 12 unique hours.
There are no scale ranges for this activity score.
|
6 weeks
|
|
Change in Respiratory Rate Between Immediate Information Period and Delayed Information Period
Time Frame: 6 weeks
|
Respiratory rate was measured as breathing rate per minute and was recorded via the wearable sensor.
Higher values reflect faster breathing which is a proxy measure of stress while lower values reflect slower breathing.
An average respiratory rate was calculated for each information period.
|
6 weeks
|
|
Change in Participant Heart Rate Variability (HRV) Between Immediate Information Period and Delayed Information Period
Time Frame: 6 weeks
|
HRV was calculated using root mean square of successive differences (rMSSD) using beats per minute recorded via the wearable sensor.
HRV scale is 0-255.
Normal scores depend on age and sex.
HRV is used as a proxy measure of stress and cardiovascular health.
An average HRV was calculated for each information period.
|
6 weeks
|
|
Change in Participant Heart Rate Between Immediate Information Period and Delayed Information Period
Time Frame: 6 weeks
|
Heart rate is measured as beats per minute and was recorded by the wearable sensor.
High values reflect faster pulse while lower values reflect lower pulse.
Normal ranges for resting adult heart rate is 60 to 100.
Higher heart rate is a proxy measure for stress and anxiety.
An average heart rate was calculated for each information period.
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marie Krousel-Wood, MD, MSPH, Tulane University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
- Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.
- Sinclair VG, Wallston KA. The development and psychometric evaluation of the Brief Resilient Coping Scale. Assessment. 2004 Mar;11(1):94-101. doi: 10.1177/1073191103258144.
- Maslach, C., Jackson, S. E., & Leiter, M. P. (1997). Maslach Burnout Inventory: Third edition. In C. P. Zalaquett & R. J. Wood (Eds.), Evaluating stress: A book of resources (pp. 191-218). Scarecrow Education
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 20, 2023
Primary Completion (Actual)
May 31, 2024
Study Completion (Actual)
May 31, 2024
Study Registration Dates
First Submitted
October 10, 2023
First Submitted That Met QC Criteria
October 10, 2023
First Posted (Actual)
October 17, 2023
Study Record Updates
Last Update Posted (Actual)
October 20, 2025
Last Update Submitted That Met QC Criteria
September 30, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-9-19
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustEnrolling by invitationOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States
-
K.G. Razumovsky Moscow State University of Technologies...RecruitingStress | Stress (Psychology)Russia
Clinical Trials on Wrist worn sensor
-
University of California, San FranciscoNational Institute on Aging (NIA)Recruiting
-
University of California, San FranciscoNational Institute on Aging (NIA)Active, not recruitingAging | MCIUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeNot yet recruitingChronic Kidney Diseases | Frailty | End Stage Renal Disease on DialysisUnited Kingdom
-
University of ZurichSwiss Federal Institute of Technology in Zurich (ETH Zurich); Tyromotion AGCompleted
-
Centre Hospitalier Universitaire DijonCompletedUnresectable Pancreatic AdenocarcinomaFrance
-
LiveMetric S.A.UnknownHeart Failure | Blood Pressure | Heart Failure,Congestive | Advanced Heart FailureUnited States
-
University of PennsylvaniaCompleted
-
Abbott Medical DevicesErasmus Medical Center; AZ Sint-Augustinus, Wilrijk; AZ Middelheim, AntwerpenCompletedChronic PainBelgium, Netherlands
-
Daniel Patterson, PhD, NRPCompletedSleep Duration | Psychomotor PerformanceUnited States
-
University of TurkuPhilips Electronics Nederland BV; Precordior Ltd; Emfit, Corp.; Everon Ltd; Remotea...CompletedPathologic Processes | Heart Diseases | Cardiovascular Diseases | Postoperative Complications | Atrial Fibrillation | Arrhythmias, CardiacFinland